Jonah Cannoy
Exelixis (United States)(US)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Protein Kinase Regulation and GTPase Signaling, Microbial Natural Products and Biosynthesis, Chemical Synthesis and Analysis, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Discovery of a Novel Class of Highly Potent, Selective, ATP-Competitive, and Orally Bioavailable Inhibitors of the Mammalian Target of Rapamycin (mTOR)(2013)65 cited
- → Discovery of a Novel Series of Potent and Orally Bioavailable Phosphoinositide 3-Kinase γ Inhibitors(2012)44 cited
- → Semisynthesis and Cytotoxicity of Hypothemycin Analogues(2007)20 cited